Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 206 of 206 entries
View as:

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)

Phase: N/A Priority: Normal
NCT ID: NCT03002571 Org: User:
Start: 07/24/18 End: 04/14/20 Due: 04/14/21

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02515097 Org: User:
Start: 11/05/15 End: 03/15/17 Due: 03/15/18

Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose

Phase: N/A Priority: Normal
NCT ID: NCT01367496 Org: User:
Start: 06/30/02 End: 08/31/02 Due: 08/31/03

Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00269412 Org: User:
Start: 12/31/05 End: 09/30/08 Due: 09/30/09

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02932306 Org: User:
Start: 11/03/15 End: 02/22/17 Due: 02/22/18

Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus

Phase: N/A Priority: Normal
NCT ID: NCT00387309 Org: User:
Start: 12/31/06 End: 11/30/07 Due: 11/30/08